Volume 28, Number 7—July 2022
Research
Measuring Basic Reproduction Number to Assess Effects of Nonpharmaceutical Interventions on Nosocomial SARS-CoV-2 Transmission
Table 2
Ward | No. beds | Total no. patients | Day of first positive case | No. cases | β | R0† | tinit |
---|---|---|---|---|---|---|---|
A2 | 48 | 62 | 11 | 30 | 1.29 (0.51–NE) | 8.76 (3.47–NE) | 2 (−14 to 29) |
C0 | 37 | 74 | 16 | 22 | 0.56 (0.22–NE) | 3.79 (1.50–NE) | 4 (−39 to 9) |
C2 | 37 | 48 | 7 | 15 | 2.13 (0.29–NE) | 14.46 (1.97–NE) | −8 (−39 to –14) |
C3 | 37 | 63 | 24 | 7 | 0.42 (0.11–1.30) | 2.87 (0.75–8.84) | 19 (−9 to 21) |
*Estimates and 95% CI for β, R0, and tinit are from the fitting the 1-phase model to data from each ward (Einit = 1). In many instances, the upper bound of the 95% CI for β, and in the most likely value of β for some wards, could not be estimated due to a flat likelihood surface, in which case the value is given as NE. NE, not estimated; β, current transmission rate per day; Einit, number of initial infections at date tinit; R0, basic reproduction number; tinit, date on which the initial infection occurs. †The R0 values were calculated using equation 4 (Appendix).
1These authors were co-principal investigators.
2Members of the workgroup are listed at the end of this article.
Page created: April 28, 2022
Page updated: June 18, 2022
Page reviewed: June 18, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.